TickerFacts.

Lunai Bioworks Inc. (LNAI): Revenue

Annual figures by period end, from SEC filings.

$52.0K
Year ended 2026-06-30
2012-03-31: $02026-06-30: $52.0K$52.0K
2012-03-31 Revenue (USD) 2026-06-30
Period endedRevenueChange YoYSource filing
2026-06-30$52.0Kn/a2026-10-13, From 2025-07-01
No annual figure between 2012-03-31 and 2026-06-30.
2012-03-31$0n/a2012-07-17, From 2011-04-01

Revenue at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Lunai Bioworks Inc. (LNAI)2026-06-30$52.0Kn/a
HCW Biologics Inc. (HCWB)2025-12-31$54.2K-97.9%
Avalo Therapeutics, Inc. (AVTX)2025-12-31$59.0K-86.6%
Connect Biopharma Holdings Ltd (CNTB)2025-12-31$64.0K-99.8%
Inovio Pharmaceuticals, Inc. (INO)2025-12-31$65.3K-70.0%
Altimmune, Inc. (ALT)2025-12-31$41.0K+105.0%
Neonc Technologies Holdings, Inc. (NTHI)2025-12-31$40.0K-51.8%
Silo Pharma, Inc. (SILO)2025-12-31$72.1K0.0%
Lyell Immunopharma, Inc. (LYEL)2025-12-31$36.0K-41.0%

Compare LNAI, HCWB, AVTX, CNTB side by side · Screen every company in Pharmaceutical Preparations ↗